VAERS reports by lot

GSK Varicella/Shingles lot 3RN95: VAERS reports

31 VAERS reports list lot 3RN95 as a GSK Varicella/Shingles vaccine, received between 2019-08-21 and 2021-01-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3533%
General / Systemic (non-local)2625%
Neurological1110%
Musculoskeletal98%
Dermatological (non-injection-site)88%
Allergic / Anaphylactic66%
Cardiac / Cardiovascular33%
Psychiatric / Neuropsychiatric33%
Respiratory22%
Gastrointestinal22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
North Carolina4
Oregon4
Pennsylvania3
South Carolina3
New York3
Washington2
Massachusetts2
Indiana1
Alaska1
Minnesota1
Wisconsin1

Reports by month received

2019-083
2019-0911
2019-105
2019-114
2019-123
2020-011
2020-031
2020-041
2020-071
2021-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.